Artwork

Content provided by Sounds of Science and Charles River. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sounds of Science and Charles River or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep. 73: Virtual Control Groups

19:51
 
Share
 

Manage episode 421928747 series 2304454
Content provided by Sounds of Science and Charles River. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sounds of Science and Charles River or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

What if we could replace mouse model control groups with a virtual equivalent? What would that mean for drug development in terms of cost, time, and animal model reduction? To answer, I am joined by Charles River associate director Laura Lotfi and Guillemette Duchateau-Nguyen from F. Hoffmann-La Roche Ltd, Pharmaceutical Sciences - Roche Innovation Center Basel. Listen now to learn how close we are to replacing some physical models with 1's and 0's.

  continue reading

74 episodes

Artwork

Ep. 73: Virtual Control Groups

Sounds of Science

62 subscribers

published

iconShare
 
Manage episode 421928747 series 2304454
Content provided by Sounds of Science and Charles River. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sounds of Science and Charles River or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

What if we could replace mouse model control groups with a virtual equivalent? What would that mean for drug development in terms of cost, time, and animal model reduction? To answer, I am joined by Charles River associate director Laura Lotfi and Guillemette Duchateau-Nguyen from F. Hoffmann-La Roche Ltd, Pharmaceutical Sciences - Roche Innovation Center Basel. Listen now to learn how close we are to replacing some physical models with 1's and 0's.

  continue reading

74 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide